Missing/wrong data?
Log in to edit
An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens
scientific article
Author/s
author: Angiolo Gadducci, Francesco Bertoni, Silvia Marsoni, Giovanni Scambia, Nicoletta Colombo
Work details
Publication date
June 1, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.